Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 515

1.

Are we ready to use precision medicine in chronic myeloid leukemia practice?

Kim DDH.

Haematologica. 2019 Dec;104(12):2327-2329. doi: 10.3324/haematol.2019.231753. No abstract available.

2.

Formulation of self-microemulsifying drug delivery system (SMEDDS) by D-optimal mixture design to enhance the oral bioavailability of a new cathepsin K inhibitor (HL235).

Visetvichaporn V, Kim KH, Jung K, Cho YS, Kim DD.

Int J Pharm. 2019 Nov 23:118772. doi: 10.1016/j.ijpharm.2019.118772. [Epub ahead of print]

PMID:
31765770
3.

Formulation And Evaluation Of Nanostructured Lipid Carriers (NLCs) Of 20(S)-Protopanaxadiol (PPD) By Box-Behnken Design.

Kim MH, Kim KT, Sohn SY, Lee JY, Lee CH, Yang H, Lee BK, Lee KW, Kim DD.

Int J Nanomedicine. 2019 Oct 25;14:8509-8520. doi: 10.2147/IJN.S215835. eCollection 2019.

4.

Predictors of the trajectory of cognitive functioning in the first 6 months after allogeneic hematopoietic stem cell transplantation.

Mayo SJ, Messner HA, Rourke SB, Howell D, Victor JC, Lipton JH, Kuruvilla J, Gutpa V, Kim DDH, Michelis FV, Metcalfe K.

Bone Marrow Transplant. 2019 Nov 19. doi: 10.1038/s41409-019-0746-3. [Epub ahead of print]

PMID:
31745248
5.

Comparative Modeling to Inform Health Policy Decisions: A Step Forward.

Kim DD, Neumann PJ.

Ann Intern Med. 2019 Nov 5. doi: 10.7326/M19-2797. [Epub ahead of print] No abstract available.

PMID:
31683277
6.

Influence of Modeling Choices on Value of Information Analysis: An Empirical Analysis from a Real-World Experiment.

Kim DD, Guzauskas GF, Bennette CS, Basu A, Veenstra DL, Ramsey SD, Carlson JJ.

Pharmacoeconomics. 2019 Oct 21. doi: 10.1007/s40273-019-00848-8. [Epub ahead of print]

PMID:
31631254
7.

Variation in US private health plans' coverage of orphan drugs.

Chambers JD, Panzer AD, Kim DD, Margaretos NM, Neumann PJ.

Am J Manag Care. 2019 Oct;25(10):508-512.

8.

My jamais vu in post allogeneic hematopoietic cell transplant: a review on secondary hemophagocytosis in adults.

Alblooshi RM, Deotare U, Michelis FV, Thyagu S, Kim DDH, Lipton JH, ElGohary GM, Viswabandya A.

Bone Marrow Transplant. 2019 Oct 14. doi: 10.1038/s41409-019-0711-1. [Epub ahead of print] Review.

PMID:
31611631
9.

Simultaneous determination of cardiovascular drugs in dried blood spot by liquid chromatography-tandem mass spectrometry.

Kim HM, Park JH, Long NP, Kim DD, Kwon SW.

J Food Drug Anal. 2019 Oct;27(4):906-914. doi: 10.1016/j.jfda.2019.06.001. Epub 2019 Jun 26.

10.

Cost Effectiveness of Nutrition Policies on Processed Meat: Implications for Cancer Burden in the U.S.

Kim DD, Wilde PE, Michaud DS, Liu J, Lizewski L, Onopa J, Mozaffarian D, Zhang FF, Wong JB.

Am J Prev Med. 2019 Nov;57(5):e143-e152. doi: 10.1016/j.amepre.2019.02.023. Epub 2019 Sep 26.

PMID:
31564600
11.

Impact of CD34+ cell dose on reduced intensity conditioning regimen haploidentical hematopoietic stem cell transplantation.

Salas MQ, Atenafu EG, Bautista MR, Prem S, Lam W, Datt Law A, Shaibani ZA, Kim DDH, Michelis FV, Lipton JH, Viswabandya A, Mattsson J, Kumar R.

Eur J Haematol. 2019 Sep 23. doi: 10.1111/ejh.13332. [Epub ahead of print]

PMID:
31549435
12.

Reduced-intensity conditioning allogeneic transplant with dual T-cell depletion in myelofibrosis.

Salas MQ, Lam W, Law AD, Kim DDH, Michelis FV, Loach D, Al-Shaibani Z, Lipton JH, Kumar R, Mattsson J, Viswabandya A.

Eur J Haematol. 2019 Dec;103(6):597-606. doi: 10.1111/ejh.13327. Epub 2019 Sep 30.

PMID:
31514253
13.

Reduced intensity allogeneic stem cell transplant with anti-thymocyte globulin and post-transplant cyclophosphamide in acute myeloid leukemia.

Salas MQ, Prem S, Atenafu EG, Law AD, Lam W, Al-Shaibani Z, Loach D, Kim DDH, Michelis FV, Lipton JH, Kumar R, Mattsson J, Viswabandya A.

Eur J Haematol. 2019 Nov;103(5):510-518. doi: 10.1111/ejh.13321. Epub 2019 Sep 9.

PMID:
31449699
14.

Impact of central nervous system involvement in AML on outcomes after allotransplant and utility of pretransplant cerebrospinal fluid assessment.

Prem S, Atenafu EG, Avena J, Bautista R, Law A, Lam W, Michelis FV, Kim DDH, Viswabandya A, Lipton JH, Mattsson J, Kumar R.

Eur J Haematol. 2019 Nov;103(5):483-490. doi: 10.1111/ejh.13314. Epub 2019 Sep 5.

PMID:
31418930
15.

A comparison of the effects of clozapine and its metabolite norclozapine on metabolic dysregulation in rodent models.

Yuen JWY, Wu C, Wang CK, Kim DD, Procyshyn RM, Honer WG, Barr AM.

Neuropharmacology. 2019 Jul 23:107717. doi: 10.1016/j.neuropharm.2019.107717. [Epub ahead of print] Review.

PMID:
31348941
16.

Leptomeningeal metastasis of classical Hodgkin lymphoma in a patient with malignant posterior reversible encephalopathy syndrome.

Kim DD, Budhram A, Haji FA, Leung A, Khaw A, Ramsay D.

Lancet Oncol. 2019 Jul;20(7):e397. doi: 10.1016/S1470-2045(19)30299-2. No abstract available.

PMID:
31267974
17.

Hypoglossal Nerve Palsy Following Chiropractic Neck Manipulation.

Chan TLH, Kim DD, Sharma M, Jog M.

Can J Neurol Sci. 2019 Sep;46(5):633-634. doi: 10.1017/cjn.2019.237. Epub 2019 Jul 31. No abstract available.

PMID:
31248469
18.

Management of sexual adverse effects induced by atypical antipsychotic medication

Downing L, Kim DD, Procyshyn RM`, Tibbo P.

J Psychiatry Neurosci. 2019 Jul 1;44(4):287-288. No abstract available.

19.

Evidence that 6q25.1 variant rs6931104 confers susceptibility to chronic myeloid leukemia through RMND1 regulation.

Woo YM, Kim S, Park JH, Lee NY, Kim JW, Kim DDH.

PLoS One. 2019 Jun 25;14(6):e0218968. doi: 10.1371/journal.pone.0218968. eCollection 2019.

20.

Laying the foundation for genomically-based risk assessment in chronic myeloid leukemia.

Branford S, Kim DDH, Apperley JF, Eide CA, Mustjoki S, Ong ST, Nteliopoulos G, Ernst T, Chuah C, Gambacorti-Passerini C, Mauro MJ, Druker BJ, Kim DW, Mahon FX, Cortes J, Radich JP, Hochhaus A, Hughes TP; International CML Foundation Genomics Alliance.

Leukemia. 2019 Aug;33(8):1835-1850. doi: 10.1038/s41375-019-0512-y. Epub 2019 Jun 17. Review.

21.

Remission clone in acute myeloid leukemia shows growth advantage after chemotherapy but is distinct from leukemic clone.

Ahn JS, Kim T, Kim YK, Cho YC, Cho S, Jung SH, Ahn SY, Jung SY, Yang DH, Lee JJ, Choi S, Lee JY, Shin MG, Yoshida K, Ogawa S, Kim IC, Zhang Z, Kim HJ, Kim DDH.

Exp Hematol. 2019 Jul;75:26-30. doi: 10.1016/j.exphem.2019.06.001. Epub 2019 Jun 12.

PMID:
31199945
22.

Recent Progress in the Development of Poly(lactic-co-glycolic acid)-Based Nanostructures for Cancer Imaging and Therapy.

Kim KT, Lee JY, Kim DD, Yoon IS, Cho HJ.

Pharmaceutics. 2019 Jun 14;11(6). pii: E280. doi: 10.3390/pharmaceutics11060280. Review.

23.

Taking stock of cost-effectiveness analysis of healthcare in China.

Butt T, Liu GG, Kim DD, Neumann PJ.

BMJ Glob Health. 2019 May 14;4(3):e001418. doi: 10.1136/bmjgh-2019-001418. eCollection 2019.

24.

Combination of the Centre for International Blood and Marrow Transplant Registry Risk Score and the Global Severity Score Enhances Prognostic Risk Stratification in Patients Receiving Frontline Therapy for Chronic Graft-versus-Host Disease.

Shapiro RM, Shin E, Law AD, Lam W, Michelis FV, Viswabandya A, Kumar R, Lipton JH, Messner H, Mattsson J, Kim DDH.

Biol Blood Marrow Transplant. 2019 Sep;25(9):1761-1769. doi: 10.1016/j.bbmt.2019.05.029. Epub 2019 Jun 4.

PMID:
31170520
25.

Painful Foot Disorders in the Geriatric Population: A Narrative Review.

Oh-Park M, Kirschner J, Abdelshahed D, Kim DDJ.

Am J Phys Med Rehabil. 2019 Sep;98(9):811-819. doi: 10.1097/PHM.0000000000001239.

PMID:
31162276
26.

Teaching NeuroImages: Steroid-responsive leukoencephalopathy in inflammatory cerebral amyloid angiopathy.

Kim DD, Gofton T, Young GB.

Neurology. 2019 Jun 4;92(23):e2732-e2733. doi: 10.1212/WNL.0000000000007612. No abstract available.

PMID:
31160413
27.

Preparation and evaluation of celecoxib-loaded proliposomes with high lipid content.

Jeon D, Kim KT, Baek MJ, Kim DH, Lee JY, Kim DD.

Eur J Pharm Biopharm. 2019 Aug;141:139-148. doi: 10.1016/j.ejpb.2019.05.025. Epub 2019 May 28.

PMID:
31150807
28.

Functional Fragments of AIMP1-Derived Peptide (AdP) and Optimized Hydrosol for Their Topical Deposition by Box-Behnken Design.

Lee JJ, Han YM, Kwon TW, Kim DH, Lee HS, Jung WJ, Kim J, Kang S, Kim SK, Cho CW, Lee KR, Kim DD, Park MC, Lee JY.

Molecules. 2019 May 22;24(10). pii: E1967. doi: 10.3390/molecules24101967.

29.

Failure of 3 different methods and biopsy sites to diagnose a patient with invasive colorectal cancer: A case report.

Kim DD, Litow KJ, Lumbra TJ, Masri MM.

Medicine (Baltimore). 2019 May;98(19):e15656. doi: 10.1097/MD.0000000000015656.

30.

Adherence to the iDSI reference case among published cost-per-DALY averted studies.

Emerson J, Panzer A, Cohen JT, Chalkidou K, Teerawattananon Y, Sculpher M, Wilkinson T, Walker D, Neumann PJ, Kim DD.

PLoS One. 2019 May 1;14(5):e0205633. doi: 10.1371/journal.pone.0205633. eCollection 2019.

31.

Formulation and bioequivalence studies of choline alfoscerate tablet comparing with soft gelatin capsule in healthy male volunteers.

Min MH, Park JH, Hur JH, Shin HC, Cho Y, Kim DD.

Drug Des Devel Ther. 2019 Apr 5;13:1049-1058. doi: 10.2147/DDDT.S193424. eCollection 2019.

32.

Toxic diffuse isolated cerebellar edema from over-the-counter health supplements.

Kim DD, Shoesmith C, Ang LC.

Neurology. 2019 May 14;92(20):965-966. doi: 10.1212/WNL.0000000000007510. Epub 2019 Apr 10. No abstract available.

PMID:
30971482
33.

Recurrent Involuntary Contractions of the Face, Arm, and Leg in an Elderly Man.

Kim DD, Budhram A, Mirsattari S.

JAMA Neurol. 2019 Jun 1;76(6):728-731. doi: 10.1001/jamaneurol.2019.0452. No abstract available.

PMID:
30933236
34.

Low rates of acute and chronic GVHD with ATG and PTCy in matched and mismatched unrelated donor peripheral blood stem cell transplants.

Prem S, Atenafu EG, Al-Shaibani Z, Loach D, Law A, Lam W, Michelis FV, Thyagu S, Kim DDH, Howard Lipton J, Kumar R, Viswabandya A.

Eur J Haematol. 2019 Jun;102(6):486-493. doi: 10.1111/ejh.13230. Epub 2019 Apr 29.

PMID:
30924973
35.

Characteristics of cooking-generated PM10 and PM2.5 in residential buildings with different cooking and ventilation types.

Kang K, Kim H, Kim DD, Lee YG, Kim T.

Sci Total Environ. 2019 Jun 10;668:56-66. doi: 10.1016/j.scitotenv.2019.02.316. Epub 2019 Feb 21.

PMID:
30852226
36.

Maxillofacial Reconstruction Using Vascularized Fibula Free Flaps and Endosseous Implants.

Patel SY, Kim DD, Ghali GE.

Oral Maxillofac Surg Clin North Am. 2019 May;31(2):259-284. doi: 10.1016/j.coms.2018.12.005. Epub 2019 Mar 5. Review.

PMID:
30846345
37.

Conversion of Intrathecal Opioids to Fentanyl in Chronic Pain Patients With Implantable Pain Pumps: A Retrospective Study.

Kim DD, Patel A, Sibai N.

Neuromodulation. 2019 Oct;22(7):823-827. doi: 10.1111/ner.12936. Epub 2019 Mar 6.

PMID:
30840355
38.

Association between Serum Lipids and Antipsychotic Response in Schizophrenia.

Kim DD, Barr AM, Fredrikson DH, Honer WG, Procyshyn RM.

Curr Neuropharmacol. 2019;17(9):852-860. doi: 10.2174/1570159X17666190228113348.

PMID:
30819084
39.

A Systematic Review of the Short-Term Health Effects of Air Pollution in Persons Living with Coronary Heart Disease.

Warburton DER, Bredin SSD, Shellington EM, Cole C, de Faye A, Harris J, Kim DD, Abelsohn A.

J Clin Med. 2019 Feb 24;8(2). pii: E274. doi: 10.3390/jcm8020274. Review.

40.

Pearls & Oy-sters: Giant descending aortic arch donut sign: Retrograde embolism as a cause of acute ischemic stroke.

Choi V, Kim DD, Fridman S, Zhang Q, Boulton M, Sposato LA.

Neurology. 2019 Feb 26;92(9):443-445. doi: 10.1212/WNL.0000000000007011. No abstract available.

PMID:
30804057
41.

Cardiovascular Health Benefits of Exercise Training in Persons Living with Type 1 Diabetes: A Systematic Review and Meta-Analysis.

Wu N, Bredin SSD, Guan Y, Dickinson K, Kim DD, Chua Z, Kaufman K, Warburton DER.

J Clin Med. 2019 Feb 17;8(2). pii: E253. doi: 10.3390/jcm8020253. Review.

42.

Influence of FLT3-ITD and NPM1 status on allogeneic hematopoietic cell transplant outcomes in patients with cytogenetically normal AML.

Pasic I, Da'na W, Lam W, Law A, Lipton JH, Viswabandya A, Kim DD, Thyagu S, Messner HA, Michelis FV.

Eur J Haematol. 2019 Apr;102(4):368-374. doi: 10.1111/ejh.13216. Epub 2019 Feb 13.

PMID:
30706524
43.

Oral Delivery of Probiotics Using pH-Sensitive Phthalyl Inulin Tablets.

Kim WS, Cho CS, Hong L, Han GG, Kil BJ, Kang SK, Kim DD, Choi YJ, Huh CS.

J Microbiol Biotechnol. 2019 Feb 28;29(2):200-208. doi: 10.4014/jmb.1811.11021.

44.

Leveraging Cumulative Network Meta-analysis and Value of Information Analysis to Understand the Evolving Value of Medical Research.

Kim DD, Trikalinos TA, Wong JB.

Med Decis Making. 2019 Feb;39(2):119-129. doi: 10.1177/0272989X18823008. Epub 2019 Jan 24. Erratum in: Med Decis Making. 2019 Nov;39(8):897.

PMID:
30678537
45.

A Serial Biofiltration System for Effective Removal of Low-Concentration Nitrous Oxide in Oxic Gas Streams: Mathematical Modeling of Reactor Performance and Experimental Validation.

Yoon H, Song MJ, Kim DD, Sabba F, Yoon S.

Environ Sci Technol. 2019 Feb 19;53(4):2063-2074. doi: 10.1021/acs.est.8b05924. Epub 2019 Feb 7.

PMID:
30673206
46.

Mobilization of Leukemic Cells Using Plerixafor as Part of a Myeloablative Preparative Regimen for Patients with Acute Myelogenous Leukemia Undergoing Allografting: Assessment of Safety and Tolerability.

Michelis FV, Hedley DW, Malhotra S, Chow S, Loach D, Gupta V, Kim DD, Kuruvilla J, Lipton JH, Viswabandya A, Messner HA.

Biol Blood Marrow Transplant. 2019 Jun;25(6):1158-1163. doi: 10.1016/j.bbmt.2019.01.014. Epub 2019 Jan 14.

PMID:
30654137
47.

Targeted Incentive Programs For Lung Cancer Screening Can Improve Population Health And Economic Efficiency.

Kim DD, Cohen JT, Wong JB, Mohit B, Fendrick AM, Kent DM, Neumann PJ.

Health Aff (Millwood). 2019 Jan;38(1):60-67. doi: 10.1377/hlthaff.2018.05148.

PMID:
30615528
48.

Evaluation of anesthesiologists' knowledge about occupational health: Pilot study.

Kim DD, Kimura A Jr, Pontes DKL, Oliveira MLS, Cumino DO.

BMC Anesthesiol. 2018 Dec 19;18(1):193. doi: 10.1186/s12871-018-0661-y.

49.

Clozapine-induced obsessive–compulsive symptoms: mechanisms and treatment

Kim DD, Barr AM, White RF, Honer WG, Procyshyn RM.

J Psychiatry Neurosci. 2019 Jan 1;44(1):71-72. No abstract available.

50.

HMGCLL1 is a predictive biomarker for deep molecular response to imatinib therapy in chronic myeloid leukemia.

Park JH, Woo YM, Youm EM, Hamad N, Won HH, Naka K, Park EJ, Park JH, Kim HJ, Kim SH, Kim HJ, Ahn JS, Sohn SK, Moon JH, Jung CW, Park S, Lipton JH, Kimura S, Kim JW, Kim DDH.

Leukemia. 2019 Jun;33(6):1439-1450. doi: 10.1038/s41375-018-0321-8. Epub 2018 Dec 16.

Supplemental Content

Support Center